SCHEMBL6965601

SCHEMBL6965601

CC(C)c1ccccc1Sc1c(O)cc(-c2ccc(Cl)c(Cl)c2)oc1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.42
TNKS O95271 2/20 0.39
PARP1 P09874 2/20 0.39
TNKS2 Q9H2K2 2/20 0.39
HDAC6 Q9UBN7 1/20 0.39
PARP2 Q9UGN5 1/20 0.39
ALOX5 P09917 3/20 0.35
ALDH1A1 P00352 4/20 0.35
RAB9A P51151 3/20 0.35
NPC1 O15118 2/20 0.35
POLB P06746 2/20 0.35
LMNA P02545 1/20 0.35
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
HSP90AA1 P07900 1/20 0.34
PTGES O14684 2/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 2/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6954281 0.89 ALDH1A1 (0.42) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL6963792 0.87 GABRP (0.43) NPSR1TNKSPARP1TNKS2HDAC6
SCHEMBL6955040 0.86 CNR1 (0.36) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL6963494 0.86 PTGES (0.43) NPSR1TNKSPARP1TNKS2HDAC6
SCHEMBL6961039 0.86 SMN1; SMN2 (0.46) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL6964073 0.85 AR (0.41) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL6960601 0.84 AR (0.41) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL6964481 0.84 TNKS (0.44) TNKSPARP1TNKS2ALDH1A1POLB
SCHEMBL6960532 0.84 MEN1 (0.43) NPSR1ALDH1A1RAB9ANPC1POLB
SCHEMBL6962847 0.84 BCHE (0.39) RAB9ANPC1PTGESSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed